Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-11-14

Clinical Trial Update: Protocol for a Multi-site Pilot Study of the OptiMed Clinical Trial [NA]

View source ↗

Summary

The protocol for a multi-site pilot OptiMed clinical trial has been withdrawn. The study targets polypharmacy and multiple chronic conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: HES-SO Valais-Wallis | Conditions: Polypharmacy, Multiple Chronic Conditions | NA | Status: WITHDRAWN